Alameda, CA, United States of America

Bingliang Chen

USPTO Granted Patents = 13 


 

Average Co-Inventor Count = 6.4

ph-index = 10

Forward Citations = 662(Granted Patents)


Company Filing History:


Years Active: 2012-2021

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bingliang Chen

Introduction

Bingliang Chen, an accomplished inventor based in Alameda, CA, has made significant strides in the field of biomedical research. With a remarkable portfolio of 13 patents, his work has the potential to transform therapeutic approaches, particularly in treating various diseases, including cancer.

Latest Patents

Among his latest innovations, Chen's patents include groundbreaking therapies such as a combination therapy utilizing an anti-fucosyl-GM1 antibody and an anti-CD137 antibody. This method offers a novel approach for treating patients afflicted with lung cancer. Additionally, his work on isolated monoclonal antibodies that specifically bind to programmed death 1 (PD-1) highlights his commitment to advancing cancer treatment. These patents encompass various components, including nucleic acid molecules that encode the antibodies, expression vectors, and methods that enhance the effectiveness of these treatments. Furthermore, Chen's invention stipulates methods for combination immunotherapy using anti-CTLA-4 and anti-PD-1 antibodies, demonstrating his expertise in the development of comprehensive treatment strategies that also address adverse events related to such therapies.

Career Highlights

Chen's career has been marked by his tenure at notable pharmaceutical companies, including Ono Pharmaceutical Co., Ltd. and E.R. Squibb & Sons, LLC. His roles in these organizations have further bolstered his experience and facilitated his contributions to innovative therapeutics.

Collaborations

Throughout his career, Chen has collaborated with esteemed colleagues such as Josephine M. Cardarelli and Alan J. Korman. These partnerships have undoubtedly contributed to the successful development and execution of his pioneering ideas and patent applications.

Conclusion

Bingliang Chen's dedication to innovation and his extensive portfolio of patents showcase his significant impact on the biomedical landscape. His work not only reflects his inventive spirit but also holds promise for advancing therapeutic methods that could improve patient outcomes in the realm of cancer and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…